Shares of Anavex Life Sciences (AVXL) have gained 15.5% over the past four weeks to close the last trading session at $9.10, but there could still be a solid upside left in the stock if short-term ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

An update from Anavex Life Sciences ( (AVXL)) is now available. On July 3, 2025, Anavex Life Sciences Corp. announced amendments to the employment agreements of its CEO, Christopher Missling, and ...

Shares of Anavex Life Sciences (AVXL) have gained 0.1% over the past four weeks to close the last trading session at $9.04, but there could still be a solid upside left in the stock if short-term ...

Anavex Life Sciences ( (AVXL)) just unveiled an update. On June 25, 2026, Anavex Life Sciences’ board set September 24, 2026, as the date for its 2026 annual meeting of stockholders and fixed July 31, ...

Anavex Life Sciences Corp. (NASDAQ:AVXL) reported a peer-reviewed publication in the journal Neuroscience Letters on Wednesday. The study shows that a pre-treatment with blarcamesine prevented Amyloid ...

On Sunday, Anavex Life Sciences Corp. (NASDAQ:AVXL) presented comprehensive results from the Phase 2b/3 study showing that blarcamesine (ANAVEX2-73), once daily orally, significantly slowed clinical ...

Anavex Life Sciences (AVXL) closed the last trading session at $6.29, gaining 4.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...